Inventor

SIEMEISTER GERHARD

DE77 patents

⚠️ This page may combine multiple inventors who share the name “SIEMEISTER GERHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIEMEISTER GERHARD

Bayer Pharma AG

2-(morpholin-4-yl)-1,7-naphthyridines

5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

Macrocyclic compounds

Substituted benzylpyrazoles

Heteroaryl substituted pyrazoles

Heteroaryl substituted pyrazoles

Macrocyclic sulfondiimine compounds

4H-pyrrolo[3,2-C]pyridin-4-one derivatives

Substituted triazolopyridines

Benzyl substituted indazoles as BUB1 inhibitors

Modified macrocyclic compounds

Combination of ATR kinase inhibitors with PARP inhibitors

Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group

4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group

SCHERING AG

Compound and a composition including such a compound

Effector conjugates, process for their production and their pharmaceutical use

Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents

CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents

N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents

Effector conjugates, process for their production and their pharmaceutical use

Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases

Lücking Ulrich

Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines

Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine

Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine

Disubstituted 5-fluoro-pyrimidines

BAYER SCHERING PHARMA AG

Macrocyclic pyrimidines, their production and use as pharmaceutical agents

CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents

CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents

Thiazolidinones, their production and use as pharmaceutical agents

Sulphimides as protein kinase inhibitors

KLAR ULRICH

Substituted benzimidazoles

Substituted imidazopyridazines

Substituted imidazopyrazines

BAYER IP GMBH

Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

Substituted benzylpyrazoles

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

BAYER AG

Predictive markers for ATR kinase inhibitors

Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease

BADER BENJAMIN

Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors

STERIX LTD

2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action

LUECKING ULRICH

Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents

HARTUNG INGO

Substituted sulphonamido phenoxybenzamides